Casdin Partners Master Fund, L.P. Plans to Sell BioLife Solutions, Inc. Common Stock

Casdin Partners Master Fund, L.P., a 10% shareholder of BioLife Solutions, Inc., has filed a Form 144 notice indicating its intention to sell 750,000 shares of BioLife Solutions' common stock. The shares were acquired through various transactions, including purchases in the open market and directly from the issuer and a shareholder. The aggregate market value of the shares to be sold is approximately $21,410,325. The notice also details recent sales of 1,000,000 shares in August 2025, which generated gross proceeds of $23,500,000. The filing highlights the significant transactions by a major shareholder, which could impact the stock's market performance.